These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1654074)

  • 21. Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study.
    Aisner J; Goutsou M; Maurer LH; Cooper R; Chahinian P; Carey R; Skarin A; Slawson R; Perry MC; Green MR
    J Clin Oncol; 1992 Aug; 10(8):1230-6. PubMed ID: 1321892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement and management of health-related quality of life in lung cancer.
    Davis K; Yount S; Wagner L; Cella D
    Clin Adv Hematol Oncol; 2004 Aug; 2(8):533-40. PubMed ID: 16163227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life in lung cancer patients.
    Gridelli C; Perrone F; Nelli F; Ramponi S; De Marinis F
    Ann Oncol; 2001; 12 Suppl 3():S21-5. PubMed ID: 11804379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung.
    Feld R; Evans WK; DeBoer G; Quirt IC; Shepherd FA; Yeoh JL; Pringle JF; Payne DG; Herman JG; Chamberlain D
    J Clin Oncol; 1984 Apr; 2(4):294-304. PubMed ID: 6323640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party.
    Hopwood P; Stephens RJ
    Br J Cancer; 1995 Mar; 71(3):633-6. PubMed ID: 7533520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial.
    Earl HM; Rudd RM; Spiro SG; Ash CM; James LE; Law CS; Tobias JS; Harper PG; Geddes DM; Eraut D
    Br J Cancer; 1991 Sep; 64(3):566-72. PubMed ID: 1654983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party.
    Br J Cancer; 1991 Feb; 63(2):265-70. PubMed ID: 1705140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of chemotherapy and radiotherapy in limited small cell lung carcinoma: results of alternating schedule in 109 patients.
    Le Chevalier T; Arriagada R; de Thé H; De Cremoux H; Martin M; Baldeyrou P; Ruffié P; Benna F; Cerrina ML; Sancho-Garnier H
    NCI Monogr; 1988; (6):335-8. PubMed ID: 2832769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experience with aprepitant in the prevention of nausea and vomiting caused by highly emetic chemotherapy of lung cancer].
    Tamási L; Müller V; Magyar P
    Magy Onkol; 2008 Jun; 52(2):179-83. PubMed ID: 18640894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can long-term survival be improved in patients with small-cell lung cancer (SCLC) and good performance status? Medical Research Council Lung Cancer Working Party.
    Bleehen NM; Girling DJ; Gregor A; Leonard RC; Machin D; McKenzie CG; Morgan DA; Smyth JF; Spittle MF; Stephens RJ
    Br J Cancer; 1994 Jul; 70(1):142-4. PubMed ID: 8018526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the receiving end--II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy.
    Coates A; Dillenbeck CF; McNeil DR; Kaye SB; Sims K; Fox RM; Woods RL; Milton GW; Solomon J; Tattersall MH
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1633-7. PubMed ID: 6315445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
    Robinson E; Haim N; Segal R; Veseley Z; Mekori T
    Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic chemotherapy before and after radiotherapy compared with radiotherapy followed by chemotherapy in the treatment of small-cell carcinoma of the bronchus: the results up to 36 months.
    Br J Cancer; 1983 Dec; 48(6):755-61. PubMed ID: 6197081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of quality of life assessment in a randomized phase III trial of small cell lung cancer--a lesson from the real world--the Swiss Group for Clinical Cancer Research SAKK.
    Hürny C; Bernhard J; Joss R; Willems Y; Cavalli F; Kiser J; Brunner K; Favre S; Alberto P; Glaus A
    Ann Oncol; 1992 Dec; 3(10):825-31. PubMed ID: 1337466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in the treatment of small cell lung cancer.
    Hosker HS; Veale D; Corris PA
    Br J Hosp Med; 1989 Aug; 42(2):129-32. PubMed ID: 2548648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer.
    Hickish TF; Smith IE; Nicolson MC; Ashley S; Priest K; Spencer L; Norman A; Middleton G; O'Brien ME
    Br J Cancer; 1998 Jun; 77(11):1966-70. PubMed ID: 9667676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: application of a general linear model.
    Morita S; Kobayashi K; Eguchi K; Matsumoto T; Shibuya M; Yamaji Y; Sakamoto J; Ohashi Y
    Jpn J Clin Oncol; 2003 Sep; 33(9):470-6. PubMed ID: 14594941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer Working Party.
    Thatcher N; Girling DJ; Hopwood P; Sambrook RJ; Qian W; Stephens RJ
    J Clin Oncol; 2000 Jan; 18(2):395-404. PubMed ID: 10637255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer.
    Arcangeli G; Righini R; Nervi C; Guerra A; Tirindelli D; Hopkins H; Looney W
    Cancer Treat Rep; 1985 Jan; 69(1):25-31. PubMed ID: 2981618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy-induced nausea and vomiting in routine practice: a European perspective.
    Glaus A; Knipping C; Morant R; Böhme C; Lebert B; Beldermann F; Glawogger B; Ortega PF; Hüsler A; Deuson R
    Support Care Cancer; 2004 Oct; 12(10):708-15. PubMed ID: 15278682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.